Phathom Pharmaceuticals(PHAT) - 2024 Q4 - Earnings Call Transcript

Phathom Pharmaceuticals (PHAT) Q4 2024 Earnings Call March 06, 2025 06:02 PM ET Company Participants Eric Ciarelli - Head Of Investor RelationsTerrie Curran - President & CEOMartin Gilligan - Chief Commercial OfficerMolly Henderson - Chief Financial & Business OfficerJoseph Stringer - Managing Director, Equity ResearchAnnabel Samimy - Managing DirectorChengxiang Liu - Vice President - Equity ResearchAzmi Nabulsi - Co-Founder & COO Conference Call Participants Yatin Suneja - Senior Managing Director, Biotech ...